Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity.

[1]  David Thompson,et al.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. , 2015, The New England journal of medicine.

[2]  J. Hirsch,et al.  Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity , 2015, AIDS.

[3]  C. Antignac,et al.  Dedifferentiation and aberrations of the endolysosomal compartment characterize the early stage of nephropathic cystinosis. , 2014, Human molecular genetics.

[4]  F. Lescure,et al.  Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[5]  B. Harding,et al.  Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients , 2013, Proceedings of the National Academy of Sciences.

[6]  Peter Reiss,et al.  Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. , 2013, The Journal of infectious diseases.

[7]  E. Christensen,et al.  Endocytic receptors in the renal proximal tubule. , 2012, Physiology.

[8]  M. Shlipak,et al.  Association of tenofovir exposure with kidney disease risk in HIV infection , 2012, AIDS.

[9]  V. D’Agati,et al.  Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. , 2010, Kidney international.

[10]  M. Tonelli,et al.  Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  A. Mocroft,et al.  Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients , 2010, AIDS.

[12]  S. de Seigneux,et al.  Immunoglobulin deposition disease with a membranous pattern and a circulating monoclonal immunoglobulin G with charge-dependent aggregation properties. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  U. Walker,et al.  Mitochondrial Tubulopathy in Tenofovir Disoproxil Fumarate-Treated Rats , 2009, Journal of acquired immune deficiency syndromes.

[14]  M. Jadoul,et al.  Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction. , 2009, Clinical nephrology.

[15]  S. Hosseini,et al.  Tenofovir renal toxicity targets mitochondria of renal proximal tubules , 2009, Laboratory Investigation.

[16]  Huy Trinh,et al.  Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. , 2008, The New England journal of medicine.

[17]  L. P. Van den Heuvel,et al.  Urinary protein excretion pattern and renal expression of megalin and cubilin in nephropathic cystinosis. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  Yuichi Sugiyama,et al.  Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir , 2007, Molecular Pharmacology.

[19]  K. Robinson,et al.  Mechanism of Active Renal Tubular Efflux of Tenofovir , 2006, Antimicrobial Agents and Chemotherapy.

[20]  G. Braden,et al.  Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  J. Gallant,et al.  Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  Joel E Gallant,et al.  Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. , 2004, JAMA.

[23]  J. Reynes,et al.  Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. , 2004, Journal of acquired immune deficiency syndromes.

[24]  P. Courtoy,et al.  Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Droz,et al.  Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  J. Rossert,et al.  Fanconi syndrome and renal failure induced by tenofovir: a first case report. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  R. Schooley,et al.  Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study , 2002, AIDS.

[28]  T. Cihlar,et al.  Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors , 2002, Antimicrobial Agents and Chemotherapy.

[29]  V. D’Agati,et al.  Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. , 2001, Human pathology.

[30]  T. Cihlar,et al.  NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS, 20(4–7), 641–648 (2001) HUMAN RENAL ORGANIC ANION TRANSPORTER 1 (hOAT1) AND ITS ROLE IN THE NEPHROTOXICITY OF ANTIVIRAL NUCLEOTIDE ANALOGS , 2003 .

[31]  S. Moestrup,et al.  Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome. , 2002, Journal of the American Society of Nephrology : JASN.

[32]  E. Bonilla,et al.  Optical imaging techniques (histochemical, immunohistochemical, and in situ hybridization staining methods) to visualize mitochondria. , 2001, Methods in cell biology.